PATENT CLAIM ANALYSIS

Application Number: 15877762
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "192000"]

Abstract:
Described are methods of treating or preventing a bacterial infection by administering an antibacterial agent comprising a β-lactamase inhibitor and one or more carbapenem to a subject.

Claim (Index 12):
The method of  claim 1  wherein the amount of \u03b2-lactamase inhibitor is sufficient to reduce the minimum inhibitory concentration of one or more carbapenems by greater or equal to 13-fold.

Metadata:
- Claim Count in Document: 33.0
- Percentile: 86.0
- Lexical Diversity: 1.12
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14888764', '15743203', '15278916', '14694550', '15463952']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7608072918518423
- 35 USC 102 Novelty (BERT): 0.5089909229709795
- Combined Prediction Score: 0.7356256549637561
- Mean Citation Score: 241.002754
- Max Citation Score: 268.85342
- Similarity Product: 190.8561641683412

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test